Sign up to save your podcasts
Or
Share Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
Paper discussed in today's episode:
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
View all episodes
By American Thoracic Society
4.1
3333 ratings
Paper discussed in today's episode:
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
More shows like Out of the Blue: An AJRCCM Podcast
View all
JAMA Editors' Summary
131 Listeners
EMCrit FOAM Feed
1,865 Listeners
NEJM This Week
324 Listeners
CHEST Journal Podcasts
62 Listeners
Core EM - Emergency Medicine Podcast
245 Listeners
JAMA Clinical Reviews
493 Listeners
The Curbsiders Internal Medicine Podcast
3,320 Listeners
JAMA Medical News
87 Listeners
Core IM | Internal Medicine Podcast
1,086 Listeners
Annals On Call Podcast
186 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
348 Listeners
Run the List
245 Listeners
Critical Care Scenarios
249 Listeners
The Curious Clinicians
366 Listeners
Critical Care Time
217 Listeners